Chimeric antigen receptor T cells targeting CD147 for non-small cell lung cancer therapy

Non-small cell lung cancer (NSCLC) is a highly malignant tumor, with a significant mortality and morbidity. With the development of tumor immunotherapy, chimeric antigen receptor T cells (CART) gets increasingly attention and achieves prominent contributions in the treatment of hematologic malignanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiao-Hong, Chen, Ruo, Shi, Ming-Yan, Tian, Ruo-Fei, Zhang, Hai, Xin, Zhi-Qian, Chen, Zhi-Nan, Wang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681039/
https://www.ncbi.nlm.nih.gov/pubmed/34896852
http://dx.doi.org/10.1016/j.tranon.2021.101309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8681039/
https://www.ncbi.nlm.nih.gov/pubmed/34896852
http://dx.doi.org/10.1016/j.tranon.2021.101309

Ejemplares similares